P630: TARGETING NEGATIVE REGULATION OF MAPK SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA

• M. Stumpf,
• V. Ecker,
• P. Giansanti,
• J. Lu,
• T. Zenz,
• I. Ringshausen,
• B. Küster,
• J. Ruland,
• M. Buchner

Affiliations

M. Stumpf

1 TranslaTUM - Central Institute for Translational Cancer Research, Technische Universität München, München

V. Ecker

1 TranslaTUM - Central Institute for Translational Cancer Research, Technische Universität München, München

P. Giansanti

2 Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich, Freising

J. Lu

3 European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

T. Zenz

4 Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland

I. Ringshausen

5 Wellcome Trust/MRC Cambridge Stem Cell Institute and Department of Haematology, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom

B. Küster

6 Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany

J. Ruland

1 TranslaTUM - Central Institute for Translational Cancer Research, Technische Universität München, München

M. Buchner

1 TranslaTUM - Central Institute for Translational Cancer Research, Technische Universität München, München